Ciliary neurotrophic factor (CNTF) has previously been shown to promote the survival of several classes of neurons and glial.
Introduction
Ciliary neurotrophic factor (CNTF)' is a 23-kD cytoplasmic protein which is expressed in both the peripheral and central nervous system beginning in the late embryonic period (1) . This protein has been shown to exhibit a variety of activities, affecting both the differentiation and survival of neural and glial cells (2) (3) (4) . CNTF shares important structural and functional properties with the cytokines interleukin 6, leukemia inhibitory factor/cholinergic determining factor (LIF/CDF), interleukin 1, and oncostatin M (5) . For this reason, CNTF is often referred to as a "neurokine" (6) .
CNTF is thought to mediate its effects through a tri-partite receptor complex composed of gp 130, the LIF ,3 receptor (LIFRf), and a CNTF-specific a receptor (CNTFRa) (7, 8) .
Whereas gp 130 and LIFRB are expressed in a broad range of tissues, expression of the a receptor is much more restricted, being confined primarily (although not exclusively) to neural cells. Functional receptors for CNTF may however exist at extraneural sites, given the distribution ofgp 130 and LIFRB, and the presence of CNTFRa in skeletal muscle and liver (8, 9) . In addition, cleavage ofthe CNTFRa glycosyl-phosphatidyl inositol linkage to produce a soluble isoform may further extend the range of CNTF responsive tissues. Such receptor "shedding" has, in fact, been observed from skeletal muscle after nerve injury (9) .
Given the potential for functional CNTF receptors at extraneural sites, we decided to examined the effects of systemic administration of CNTF. CNTF exhibits a short biological half-life in vivo (1O); thus making it difficult to maintain stable levels of this agent systemically. We therefore developed stable cell lines which expressed either a secreted (CNTF-s) or nonsecreted (CNTF-ns) form of rat CNTF. Implantation ofa known quantity of these cells produced a relatively stable amount of active neurotrophic agent whose effects were determined. We observe that mice receiving CNTF-s but not CNTF-ns cells exhibit a loss of body mass which is much more extensive than that reported for previously described cachectins. These data also demonstrate that the CNS effects of CNTF represent only one segment of its biological activities.
Methods
Construction and expression ofCNTF-producing cells. For both secretory and nonsecretory CNTF expression constructs, the 600-bp fulllength rat CNTF cDNA was placed under the control of the 2.56-kb glial fibrillary acidic protein (GFAP) promoter (kindly provided by K. Mikoshiba, Osaka, Japan). The CNTF secretion construct contained an additional 80-bp fragment that encoded the human growth hormone signal sequence, which was fused in-frame to the start of the CNTF cDNA. Stable cell lines were produced by lipofectin-mediated transfection as previously described (1 1 Western analyses. Samples were resolved by on a 15% polyacrylamide gel by SDS-PAGE as previously described (1 1). After separation, proteins were transferred to nitrocellulose membranes (Schleicher & Schull Inc., Keene, NH; BA85) via electrophoretic transfer as described (1 1). After blocking with casein, affinity-purified CNTF anti-peptide antibody (12) was then added for a period of 4-12 h at 250C with mild agitation. After removal of the primary antibody, the secondary antibody (Promega Corp., Madison, WI; alkaline phosphatase anti-rabbit) was then added at a dilution of 1:1,500 in wash buffer, and incubated for 2 h at room temperature with mild agitation. Blots were developed for 20 min, using a bromochloroindolyl phosphate/nitroblue tetrazolium substrate (0.0 165% and 0.033%, respectively), and reactions were stopped by rinsing blots in PBS, pH 8.0, containing 20 mM EDTA.
Immunohistochemistry. Cultures of CNTF-producing cells and peritoneal sections from animals receiving CNTF cell implants were fixed in methanol (-20'C) or 4% paraformaldehyde, respectively. Samples were blocked with 10% normal goat serum for 30 min, and incubated with affinity-purified anti-CNTF antibody (1:500 dilution of a 5 ug/ml stock, in 1% normal goat serum/2% normal mouse serum/0. 1 M PBS) overnight at 40C. Samples were subsequently washed and incubated with biotinylated IgG (1:200 dilution ofgoat anti-rabbit or horse anti-mouse) for 40 min at room temperature, washed, and then incubated with avidin-horseradish peroxidase (1:200 dilution of standard Elite kit; Vector Labs, Burlingame, CA) for 30 min. Samples were then reacted with 1 mg/ml diaminobenzidene (Sigma Chemical Co., St. Louis, MO) 0.02% vol/vol hydrogen peroxide to make visible the antigen-antibody complexes.
Cytokine and haptoglobin assays. Sera were obtained by standard methods (13) and analyzed for the cytokines indicated below. CNTF activity was determined using a chick ciliary ganglion survival assay as described previously (14) . In all cases, addition ofanti-CNTF antibody was found to inhibit the trophic activity present, thus confirming its identity. TNFa was assessed by TNFa-specific ELISA (Genzyme Corp., Cambridge, MA; no. 1509-00), according to the manufacturer's instructions. IL-6 activity was determined using a B9 plasmacytoma proliferation assay, as described previously (15) . This cell line has been shown previously to be insensitive to CNTF, LIF, and TNF a (9) . LIF trophic activity was determined using an Ml (ATCC TIB No. 192) proliferation assay, as described previously (16) . This cell line been shown to respond to LIF and IL-6, but not CNTF or TNF a (9) . Results for a given sample were thus compared with those obtained from the IL-6 assay for the identical sample. For IL-6 and LIF assays, colorimetric assessment of cell proliferation (MTT) was used in place of the described method. The lower limit of sensitivity for each assay was as follows: TNFa 80 pg/ml, IL-6 10 pg/ml, LIF 100 pg/ml, and CNTF 100 pg/ml.
Haptoglobin concentrations were determined on triplicate dilutions ofmurine sera by rocket immunoelectrophoresis (13) against haptoglobin antisera. A set of standards of known concentration was run for each set.
Determination of lean body mass. 1 wk after i.p. implantation of cells, animals were killed and dissected to remove the skin, tail, and internal organs. Remaining body fat, if present, was also removed. The weight of the remaining carcass (primarily the skeleton and skeletal muscle) was then determined and reported as "lean body weight." Measurement ofcoordination and grip strength. 
Results
In order to produce CNTF from rat C6 glioma cells, gene cassettes encoding either a secretory or nonsecretory form of rat CNTF were placed under the control ofthe GFAP promoter, as shown in Fig. 1 A. Western analyses demonstrate that both the CNTF-s and CNTF-ns cell lines, but not the parental C6 line, exhibit a protein doublet of -23 kD with a minor species present at 40 kD ( Fig. 1 B) , as previously described for purified CNTF (14, 17) . Densitometric scans of Western blots from several independent cultures indicate that the CNTF-ns line produces -6 jig of CNTF/1 X 106 cells per 24 h in serum-free media, with 97% of the protein present in the cytoplasmic fraction. The secretory CNTF line produces~-8.2 pLg of CNTF/1 X 106 cells per 24 h in serum-free media, with 86% of this activity present in the culture medium. Bioassays of culture medium from the CNTF secretory lines indicate that the trophic activity present is comparable on a molar basis to that observed with the nonsecretory line and purified rat sciatic nerve CNTF in dorsal root (rat) and ciliary ganglia (chick) cultures (data not shown). Thus these CNTF-expressing cell lines produce biologically active CNTF which is targeted to the appropriate cellular compartment. Immunohistochemical staining ofthese cells ( Fig. 1 C) showed intense staining in the perinuclear region, at the Golgi apparatus, consistent with the localization observed for other secreted proteins.
Implantation and effects of CNTF-expressing cells. 9-wkold CD 1 mice receiving i.p. implants of 1 X 106 cells were divided into four basic groups. Animals received either: (a) cell dilution medium alone (CDM), (b) the parental rat C6 cell line (C6), (c) the CNTF-ns cell line, or (d) the CNTF-s cell line. Implantation of C6 glioma cells within the peritoneal cavity resulted in the continued growth and proliferation of these cells, particularly along collagenous mesenteries. CNTF-s and CNTF-ns cells appeared to proliferate at similar rates, with the nonsecretory cells exhibiting a slightly higher mitotic index. Since these cells express 3-galactosidase, they could be unequivocally identified from the surrounding tissue (Fig. 1 D) .
Implantation of nonsecretory and secretory CNTF-expressing cells had vastly different effects on the recipient animals. Little change in body mass was observed for animal injected with the cell dilution media, whereas the C6 and CNTFns-injected animals showed small increases due to the retention of ascites fluid (Fig. 2 A) animals exhibit a substantial depression in fluid intake which is Time (days) not observed in the other treatment groups. This CNTF-inange in total body weight in the presence of CNTF-exduced thirst suppression could be observed within 6 h after cell Error bars indicate the maximum range observed at implantation, and was thus a relatively early consequence of nt for each group. Arrows indicate the time point at CNTF action. This effect probably contributed to the subse--s treated animals differed significantly from other treatquent loss ofbody mass in these animals (22) . Note that CNTF-(a, P < 0.05). (A) 9-wk-old litters ofCDl mice weighing ns (but not C6)-treated animals also exhibited some depression eived 200 Al i.p. injections of cell dilution medium in fluid intake. This may reflect a small amount ofCNTF "leakr 1 X 106 cells of the following: rat C6 glioma cells (C6, age" from these cells (see Table II Effects of recombinant CNTF. In order to verify that the effects observed with secreted CNTF were not due to a serendipitous interaction via the altered amino terminus (which was fused to the human growth hormone signal sequence), adult CDl mice were injected with recombinant rat (rrCNTF) or human CNTF (rhCNTF). rrCNTF was produced from a bacterial expression plasmid (pGEX-2T) containing the complete rat CNTF cDNA fused to glutathione S-transferase (14) . Thrombin cleavage of this product from a glutathione affinity matrix resulted in the addition of two amino acids (Gly, Ser) to the protein. This modification was distinct from that potentially present on CNTF-s, and has been shown not to perturb the biological properties of CNTF (14)-consistent with previous observations (23) . The rhCNTF used in this study was identical to endogenous human CNTF (Scios, Nova, Mountain View, CA). 2 ,gg of CNTF was injected i.p. three times per day, in order to compare the results obtained with those previously observed using LIF (24) . These data (Fig. 3 B) demonstrate that i.p. injection of rrCNTF or rhCNTF caused a decrease in body mass similar to that observed with 1 X 106 CNTF-s cells.
Further evidence that the CNTF secreted from C6 cells faithfully reproduced the biological activity of the nonsecreted (endogenous) CNTF protein was suggested from a small number ofCNTF-ns animals which did not eliminate the implanted cells. These animals eventually developed proliferative CNTFns tumors (18-21 d) and were invariably sacrificed due to cachectic wasting. This was not observed in animals which developed proliferative C6 tumors (which were killed due to tumor proliferation). Thus both secreted and nonsecreted forms of CNTF could induce cachexia, which was not observed with the parental C6 tumor line alone. Taken together, these data indicate that the cachectic effects observed represent bona fide actions of the CNTF protein.
Analysis of cachectic cytokines. In order to determine whether the results obtained using CNTF reflected secondary induction of other known cachectins, samples of murine sera were assayed for various cytokines. As shown in Table II , detectable levels of TNFa (>80 pg/ml), LIF (>100 pg/ml), or IL-6 (>10 pg/ml) were not observed in any group. The levels present (if any) were thus substantially below that required to induce even moderate cachectic wasting (24) (25) (26) , suggesting that CNTF acts independently of these factors. Analysis of sera from animals receiving 1 X 106 CNTF-s cells revealed the presence of substantial quantities of ciliary ganglion trophic activity however (10 ng/ml). This trophic activity could be blocked by the addition of polyclonal rabbit CNTF antisera which inhibits CNTF activity in vitro (data not shown). Significant concentrations of CNTF were also observed in the sera of animals which received 1 X 106 CNTF-ns cells 7 d before (-3 ng/ml). This value may be higher than expected owing to small amounts of immune-mediated cell lysis which may be occurring at this time.
Discussion
These data demonstrate that CNTF, when present systemically, induces a severe form ofcachexia in both adult mice and neonatal rats. This effect was observed using implants of Mice implanted with 1 X 106 cells at day 0 were killed on day 7 and dilutions of their sera analyzed for cytokines indicated. The lower limit of sensitivity for each assay is as follows: TNFa 80 pg/ml, IL-6 10 pg/ml, LIF 100 pg/ml, CNTF 100 pg/ml; n 2 7 individuals per group.
CNTF-secreting cells, and was not found with nonsecreting CNTF-expressing cells or the parental C6 cell line. The degree of wasting was proportional to the number of CNTF-secreting cells implanted, and at saturating levels induced a 35% loss in body mass over a 1-wk time period. These effects could be reproduced by injection of recombinant rat or human CNTF protein, and appeared to be independent ofTNFa, IL-6, or LIF induction. The results indicate that CNTF is directly involved in the induction ofcachexia, and defines a new biological activity for this protein.
Implantation of 1 X I05 CNTF-s cells did not lead to significant wasting, while implantation of 1 X 106 cells resulted in overt cachexia. These data suggest that a "threshold" ofbiologically active CNTF is required to bring about overt cachexia. This threshold is on the order of 100-200 ng/g weight per day for mice receiving i.p. injections of CNTF protein, and 5-10 ng/ml serum for mice implanted with CNTF secretory cells. This latter concentration is similar to that used previously to determine the effects of CNTF on a variety of neural cells in vitro (3, 4, 27) . This indicates that the mechanism that mediates CNTF's cachectic response is of the same order of affinity as that mediating its survival properties in neural cells.
CNTF exhibits closest homology to IL-6 and LIF (5). Similarly, CNTFRa shares strongest homology with these cytokine receptors (6) . The IL-6 receptor is composed of IL-6Ra and gp 130, the LIF receptor is composed of gp 130 and LIFRf3, and the CNTF receptor is composed of gp 130, LIFRfl and CNTFRa (6, 7, 28, 29) . Thus, to a first approximation, IL-6, LIF and CNTF define a progressively restricted range ofbiological activities, largely due to spatial restriction of their receptor components (6, 8) . An understanding of the biological activities which these factors share, such as cachexia and the induction of hepatic acute-phase proteins, may therefore best be determined through an examination of CNTF, which is more restricted in its sites of action. Analysis of CNTF-induced cachexia suggests that the liver, and perhaps skeletal muscle (sites of peripheral CNTFRa expression), are the primary sites mediating the induction ofthe cachectic state. While CNTF receptors are also expressed within the central nervous system (8, 9) , interaction ofCNTF directly with these sites does not appear to play a major role in the induction of cachexia (see below).
While CNTF, IL-6, and LIF all induce some degree ofwasting, the strength of these effects appear to differ. Animals treated with CNTF appear to develop a more rapid and extensive form of wasting compared to these other cytokines (24, 25) . While this may be due to variations in signal transduction at their respective cellular targets, it more probably reflects differences in the effective concentration of the cytokine at its sites ofaction. This may be influenced by factors such as biological half-life, number of receptor sites, subunit expression and receptor density.
Previously, high levels of CNTF protein (1.5-7 ,ug/day) have been introduced into the rat central nervous system via miniosmotic pumps at several intracranial sites (30, 31) , without report of cachectic wasting. We have also failed observed cachexia in adult rats and mice receiving intracranial implants of CNTF-s cells. This suggest that the CNTF present within the central nervous system is inaccessible to those cellular targets which mediate its cachectic effects.
With regard to systemic administration, Sendtner et al. (10) have reported that implantation of embryonic stem cells producing a pre-pro nerve growth factor/murine CNTF product, can prevent motoneuron degeneration in pmn mice. Surprisingly, no mention of wasting is made for these animals, despite reporting CNTF serum levels of 500 U/ml. The effects ofintroducing purified CNTF protein have thus far not been described for this mutant. While the primary defect ofpmn is unknown, it is possible that it interferes with the pathway required for the mediation ofCNTFs cachectic effects. In addition, this discrepancy may be due differences in the CNTF protein produced, as the pre-pro NGF region does not have a well-defined initiation or cleavage site. CNTF induces catabolism of stored fat, skeletal muscle protein, and liver glycogen, and also depresses circulating concentrations of several intermediary metabolites (Henderson, J. T., N. A. Seniuk, J. Gauldie, B. Mullen, and J. C. Roder, manuscript submitted for publication); in a manner reminiscent of metabolic starvation. CNTF does not appear to be predominantly anoretic in nature, as CNTF-s animals exhibit insufficient reductions in food intake to explain the observed loss in body mass. CNTF did however cause a pronounced decrease in fluid intake in these animals. The rapid onset and degree of thirst suppression suggests that this is an early consequence of CNTF action, and no doubt contributes to the observed cachexia. The periventricular and supraoptic nuclei, are sites known to be involved in the regulation of thirst behavior in rodents (22) . The blood-brain barrier proximal to this region contains fenestrations, suggesting a direct mechanism for CNTF in altering fluid intake. However, intracranial application of CNTF by ourselves and others argue against such a straightforward interaction. We believe that the majority of CNTF's cachectic effects result from the direct interaction of this neurokine with peripheral targets such as liver hepatocytes (8, 21 ). This in turn induces secondary mediators, such as the acute phase proteins which may interact with additional sites, altering metabolic function. Studies performed in vitro using hepatoma cell lines demonstrate that these cells express functional receptors for CNTF (and other cachectins), and that application ofCNTF directly induces the synthesis ofacute phase proteins (21, 32) . Given the central regulatory role of the liver in intermediary metabolism, and its expression of a number of different cachectin receptors, it would appear to be a likely candidate as the prime mediator of cachectin action.
Much remains to be learned regarding the biochemical mechanism of cachectic wasting. It is interesting to note that many of the effects observed in CNTF-s-treated animals are similar to those seen in hyperthyroidism (33) . In addition, several features of these animals, such as thymic atrophy, suggest alterations in their levels of glucocorticoids (Henderson, J. T., N. A. Seniuk, J. Gauldie, B. Mullen, and J. C. Roder, manuscript submitted for publication). Examination ofthe potential influence of CNTF on these metabolic hormones may provide a better understanding ofits cachectic mechanism. With regard to triglyceride mobilization, it will be ofinterest to see ifCNTF can alter the activity of catabolic enzymes such as lipoprotein lipase, which have been shown to be suppressed by LIF, and TNFa (34, 35) .
The data obtained indicate that CNTFexhibits major activities outside the nervous system proper in adult mice, demonstrating that the effects ofCNTF on neural cells represents only a subset of the biological properties of this factor. These extraneural effects include the induction of rapid cachectic wasting, and the synthesis of the acute phase protein haptoglobin. In addition, animals receiving CNTF exhibited thymic atrophy, gall bladder enlargement, and elevations in red blood cell content as detailed elsewhere (Henderson, J. T., N. A. Seniuk, J. Gauldie, B. Mullen, and J. C. Roder, manuscript submitted for publication). CNTF mediated cachexia may provide a more specific model in which to examine this phenomenon in vivo. Understanding the mechanism of these CNTF-induced effects may be important, both in terms of defining the physiology of this factor, and in exploring its clinical applications for neural repair.
